| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
,
RAMONA G ALMIREZ,
JOHN W. HOLADAY and
CAROL GRACE SMITH
Department of Pharmacology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814 Bethesda, Maryland 20814
Division of Neuropsychiatry, Walter Reed Army Institute of Research Washington, D.C. 20307–5100
The role of endogenous opioid peptides (EOP)in the neuroendocrine control of primate gonadotropin and PRLsecretion was studied in nonrestrained adult male rhesus monkeys.Morphine (0.5β1.0 mg/kg) was used as the prototypeopiate, β-endorphin (β-END; 10-20 µg/kg) and [D-Ala2,D-Leu5]enkephalin (DADLE; 5β20 mg/kg) were used as representativesof EOP, and naloxone (0.5β2.0 mg/kg) was used as an opiatereceptor blocker. Drugs were administered and blood was collected(at 20-min intervals for 4 h) through an indwelling jugularcatheter. LH and PRL levels were measured in plasma by RIA.
Intravenous administration of morphine (1.0 µg/kg) and DADLE (10 g/kg) produced decreases in LH levels of 64% and40%, respectively. These decreases occurred within 1 h afterdrug injections and lasted for approximately 3 h. (β-END had noeffect on LH levels. Naloxone, at all doses studied, significantlyincreased LH levels (5- to 8-fold). The LH rises occurred within20 min and lasted for up to 2 h. Both morphine and β-END produced immediate increases in PRL, which remained elevatedfor 3 h. DADLE did not alter PRL levels. Naloxone (1.0 and 2.0mg/kg) decreased PRL concentrations (45% and 60%, respectively).
Pretreatment with morphine or DADLE did not alter the LHresponse to GnRH (100 µg) stimulation, indicating a hypothalamicsite of action for the opioid inhibition of LH release.Naloxone administration reversed the inhibitory effects of morphineand DADLE on LH. The stimulatory effect of morphineon PRL levels was also reversed by naloxone. These studiesfurther define the postulated physiological role of EOP in primatereproductive neuroendocrinology. Based on receptor selectivities of these opioid agonists, the inhibition of LH may bemediated by
-receptors, whereas PRL release appears to be µmediated.
* This work was supported by USUHS. Preliminary findings were reported in part at the American Society of Andrology, 1983 meeting.
Present address: Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California 94143
Received June 27, 1984.
This article has been cited by other articles:
![]() |
J. W. Hill, J. K. Elmquist, and C. F. Elias Hypothalamic pathways linking energy balance and reproduction Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E827 - E832. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |